doi:10.1007/s12250-020-00332-0

[1]
Eman Teer, Danzil E. Joseph, Leanne Dominick, Richard H. Glashoff, M. Faadiel Essop, 2021: Expansion of GARP-Expressing CD4⁺CD25^-FoxP3⁺ T Cells and SATB1 Association with Activation and Coagulation in Immune Compromised HIV-1-Infected Individuals in South Africa, Virologica Sinica, 36, 1133-1143. doi: 10.1007/s12250-021-00386-8
[2]
Ling Ma, Shumin Chen, Zhen Wang, Saisai Guo, Jianyuan Zhao, Dongrong Yi, Quanjie Li, Zhenlong Liu, Fei Guo, Xiaoyu Li, Pingping Jia, Jiwei Ding, Chen Liang, Shan Cen, 2021: The CREB Regulated Transcription Coactivator 2 Suppresses HIV-1 Transcription by Preventing RNA Pol Ⅱ from Binding to HIV-1 LTR, Virologica Sinica, 36, 796-809. doi: 10.1007/s12250-021-00363-1
[3]
Zhenyuan Wang, Chunjun Qin, Jing Hu, Xiaoqiang Guo, Jian Yin, 2016: Recent advances in synthetic carbohydrate-based human immunodeficiency virus vaccines, Virologica Sinica, 31, 110-117. doi: 10.1007/s12250-015-3691-3
[4]
Chinwe O. Ewenighi-Amankwah, Charles Chinedum Onyenekwe, Ogochukwu Udemba, Patience Muogbo, Lijun Rong, 2020: A Mother-to-Child Transmission Study in Nigeria: The Impact of Maternal HIV Infection and HAART on Plasma Immunoglobulins, Cytokine Profiles and Infant Outcome, Virologica Sinica, 35, 468-477. doi: 10.1007/s12250-020-00202-9
[5]
Yan Yan, Yong Ren, Renfang Chen, Jing Hu, Yongjia Ji, Junyang Yang, Jiayin Shen, Lvyin Hu, Hao Pei, Jun Wang, Yuanwang Qiu, Hongzhou Lu, Lihua Huang, 2018: Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study, Virologica Sinica, 33, 227-233. doi: 10.1007/s12250-018-0028-z
[6]
Xue-qing Chen, Chang Liu, Xiao-hong Kong, 2011: The Role of HIV Replicative Fitness in Perinatal Transmission of HIV, Virologica Sinica, 26, 147-155. doi: 10.1007/s12250-011-3180-2
[7]
Yanpeng Li, Ulf Dittmer, Yan Wang, Jiping Song, Binlian Sun, Rongge Yang, 2016: The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection, Virologica Sinica, 31, 207-218. doi: 10.1007/s12250-016-3725-5
[8]
Krystelle Nganou-Makamdop, Daniel C. Douek, 2019: Manipulating the Interferon Signaling Pathway: Implications for HIV Infection, Virologica Sinica, 34, 192-196. doi: 10.1007/s12250-019-00085-5
[9]
Shouli Wu, Min Gao, Jian Zheng, Pingping Yan, Wei Wang, Xiaoli Lu, Yuefeng Qiu, Yansheng Yan, 2019: Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China, Virologica Sinica, 34, 358-366. doi: 10.1007/s12250-019-00130-3
[10]
Lei KANG, Jing HU, Xue-shan XIA, Jian-guo WU, 2007: HIV and HCV: from Co-infection to Epidemiology, Transmission, Pathogenesis, and Treatment, Virologica Sinica, 22, 443-450.
[11]
Yan JIANG, 2007: Development and Challenge of HIV/AIDS Testing Laboratory Network and Quality Assurance System in China, Virologica Sinica, 22, 434-442.
[12]
Xin Chen, Mei Ye, Yu Wang, Chiyu Zhang, Yong-Tang Zheng, 2020: Laos is Affected by HIV CRF01_AE and the Newly Identified CRF97_01B, Virologica Sinica, 35, 538-547. doi: 10.1007/s12250-020-00215-4
[13]
Michael WEN, Hui YANG, Paul ZHOU, 2007: "Unconventional" Neutralizing Activity of Antibodies Against HIV, Virologica Sinica, 22, 462-470.
[14]
Jie Jia, Hong-Yi Zheng, Yu Zhao, Kai-Cheng Gao, Deshenyue Kong, Danfeng Lu, Ji-Qun Yang, Jun-Hong Mao, Xiuwen Wang, Kun-Hua Wang, Bin Su, Jian-Hua Wang, Yong-Tang Zheng, Yi-Qun Kuang, 2025: A decreased proportion of naïve MAIT cells is associated with the incomplete immune reconstitution in antiretroviral therapy-treated HIV-1 patients, Virologica Sinica, 40, 962-976. doi: 10.1016/j.virs.2025.12.003
[15]
Hai-Bo Ding, Hong Sun, Yong-Hui Feng, Qing-Hai Hu, Qi Wang, Nan Li, Qing-Qing Ma, Wen Tian, Yan-Chun Peng, Jia-Qi Chen, Jin-Li Song, Hua-Lu Cui, Hai-Long Li, Wen-Qing Geng, Tao Dong, Xiao-Xu Han, Hong Shang, 2026: Characteristics of humoral and T-cell immune responses in people living with HIV after breakthrough SARS-CoV-2 Omicron variant infection during December 2022 to January 2023, Virologica Sinica, 41, 84-96. doi: 10.1016/j.virs.2026.01.003
[16]
Jiantao Fu, Yifan Guo, Guoxiang Zheng, Zongxing Yang, Jinchuan Shi, Dingyan Yan, Jianhua Yu, Lijun Sun, Hongxin Zhao, 2025: Efficacy and safety of switching from lopinavir/ritonavir-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV: A multicenter retrospective study, Virologica Sinica, 40, 835-841. doi: 10.1016/j.virs.2025.10.003
[17]
Qingrong Zhang, Lijun Sun, Yuxuan Liang, Wenlu Zou, Jingtao Huang, Yuan Zhang, Yi Jin, Na Zhou, Jiangzhu Ye, Huachun Zou, Hao Wu, Tong Zhang, Bin Su, Taiyi Jiang, Haitao Chen, 2025: Patterns of liver fibrosis evolution in Chinese HIV/HBV co-infected adults following 5-year antiretroviral treatment: A longitudinal study using non-invasive APRI and Fib-4 scores, Virologica Sinica, 40, 118-124. doi: 10.1016/j.virs.2024.12.009
[18]
刘佳建, 刘淑红, 陈启民, 耿运琪, 1999: Activation of Bovine Immunodeficiency Virus(BIV) Gene Expression by Bovine Spumavirus(BSV), Virologica Sinica, 14, 249-254.
[19]
Wenyuan Shen, Bin Liu, Zhou Liu, Jiabin Feng, Chang Liu, Xiaohong Kong, 2017: Host protein atlastin-1 promotes human immunodeficiency virus (HIV-1) replication, Virologica Sinica, 32, 338-341. doi: 10.1007/s12250-017-3998-3
[20]
Li Yuan, Wen-Jiang Chen, Jia-Ye Wang, Yan Li, Dan Tian, Ming-Xia Wang, Hao-Tong Yu, Ying-Chu Xu, Di Li, Min Zhuang, Hong Ling, 2018: Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses, Virologica Sinica, 33, 502-514. doi: 10.1007/s12250-018-0074-6